Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-03-14
2008-11-18
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07452877
ABSTRACT:
Methods are disclosed for treating hyperalgesia associated with irritable bowel syndrome comprising administering a direct and selective inhibitor of MLCK.
REFERENCES:
patent: 6248549 (2001-06-01), Van Eyk et al.
patent: 6696480 (2004-02-01), Liao
patent: 2002/0045564 (2002-04-01), Van Eyk et al.
patent: 0 797 992 (1997-10-01), None
patent: 2 148 997 (2000-05-01), None
patent: WO 98/14186 (1998-04-01), None
patent: WO 98/37096 (1998-08-01), None
patent: WO 99/14242 (1999-03-01), None
patent: WO 00/03746 (2000-01-01), None
patent: WO 00/07609 (2000-02-01), None
patent: WO 02/058687 (2000-08-01), None
patent: WO 00/57727 (2000-10-01), None
patent: WO 02/14499 (2002-02-01), None
Bradesi et al., Neurogastroenterol. Mot. (Feb. 2002) 14(1), 75-82.
Toulouse et al., British Journal of Pharmacology (2000) 129(1), 193-199.
Turner et al, “Physiological Regulation of Epithelial Tight Junctions Is Associated With Myosin Light-chain Phosphorylation”, American Journal of Physiology, American Physiological Society, Bethesda, MD, US, vol. 273, No. 4, Part 1, Oct. 1997, pp. C1378-C1385.
Ma et al, “Ethanol Modulation of Intestin Epithelial Tight Junction Barrier”, American Journal of Physiology, American Physiological Society, Bethesda MD, US, vol. 276, No. 4, Part1, Apr. 1999, pp. G965-G974.
Heyman et al, “Cytokine-Induced Alteration of the Epithelial Barrier to Food Antigens in Disease”, Annals of The New York Academy of Sciences, New York Academy of Sciences, New York, NY, US, vol. 915, 2000, pp. 304-311.
Gassler et al, “Inflammatory Bowel Disease is Associated with Changes of Enterocytic Junctions”, American Journal of Physiology: Gastrointestinal and Liver Physiology, American Physiological Society, US, vol. 281, No. 1, Jul. 2001, pp. G216-G228.
Kucharzik et al, “Neutrophil Transmigration in Inflammatory Bowel Disease is Associated with Differential Expression of Epithelial Intercellular Junction Proteins”, American Journal of Pathology, Philadelphia, PA, US, vol. 159, No. 6, Dec. 2001, pp. 2001-2009.
Database Medline, US National Library of Medicine (NLM), Bethesda, MD, US; Feb. 2002, Cho So Yean et al, “Enhancement of paracellular transport of heparin disaccharide across Caco-2 cell monolayers”, & Archives of Pharmacal Research, Korea (South), Feb. 2002, vol. 25, No. 1, Feb. 2002, pp. 86-92.
Mi Won Son et al, “Protective Effect of Taurine on TNBS-Induced Inflammatory Bowel Disease in Rats”, Archives of Pharmacal Research, Natl. Fisheries University, Pusan, KR, vol. 21, No. 5, Oct. 1998, pp. 531-536.
Simonovic et al, “EnteropathogenicEscherichia coliDephosphorylates and Dissociates Eccludin from Intestinal Epithelial Tight Junctions”, Cellular Microbiology, Blackwell Science, Oxford, GB, vol. 2, No. 4, Aug. 2000, pp. 305-315.
Simmons et al, “Bidirectional Sodium Ion Movement via the Paracellular and Transcellular Routes Across Short-Circuited Rabbit Ileum”, Biochimica et Biophysica Acta, Amsterdam, NL, vol. 448, No. 3, 1976, pp. 426-450.
Fasano et al, “Zonula Occludens Toxin Modulates tight Junctions Through Protein Kinase C-Dependent Actin Reorganization, in Vitro”, Journal of Clinical Investigation, New York, NY, US, vol. 96, Aug. 1, 1995, pp. 710-720.
Karayiannakis et al, “Expression of Catenins and E-Cadherin During Epithelial Restitution in Inflammatory Bowel Disease”, Journal of Pathology, Chichester, Sussex, GB, vol. 185, No. 4, Aug. 1998, pp. 413-418.
Soderholm et al, “Augmented Increase in Tight Junction Permeability by Luminal Stimuli in the Non-Inflamed Ileum of Crohn's Disease”, Gut, British Medical Association, London, GB, vol. 50, No. 3, Mar. 2002, pp. 307-313.
Perry et al, “Reduced Cadherin-Catenin Complex Expression in Celiac Disease Can Be Reproduced in Vitro by Cytokine Stimulation”, Laboratory Investigation, United States and Canadian Academy of Pathology, Baltimore, US, vol. 79, No. 12, Dec. 1999, pp. 1489-1499.
Patent Abstracts of Japan vol. 1998, No. 01, Jan. 30, 1998 & JP 09 241177, Sep. 16, 1997.
Groot, “Correlation Between Electrophysiological Phenomena and Transport of Macromolecules in Intestinal Epithelium”, Veterinary Quarterly, Kluwer, Dordrecht, NL, vol. 20, No. Suppl 3, Jun. 1998, pp. S45-S49.
Savkovic et al, “EPEC-Activated ERK1/2 Partcipate in Inflammatory Response BT Not Tight Junction Barrier Disruption”, American Journal of Physiology: Gastrointestinal and Liver Physiology, American Physiological Society, US, vol. 281, No. 4, Oct. 2001, pp. G890-G898.
Fasano et al, “Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease”, LANCET, XX, XX, vol. 355, No. 9214, Apr. 29, 2000, pp. 1518-1519.
Kiliaan et al, “Stress stimulates transepithelial macromolecular uptake in rat jejunum”, American Journal of Physiology 1998 United States, vol. 275, No. 5, 38-5, 1998, pp. G1037-G1044.
Verhaeren et al, “The Effect of 2,4,6-Triaminopyrimidine on Increased Mucosal Permeability of Guinea-Pig Colonic Mucosa, Following Administration of 1,8-Dihydroxy-Anthraquinonem, Salicylic Acid and Dinitrophenol”, Pharmaceutisch Weekblad Scientific Edition, Bohn, Scheltema and Holkema, Amsterdam, NL, vo. 3, No. 1, Feb. 20, 1981, pp. 815-819.
Database Biosis, Biosciences Information Service, Philadelphia, PA, US; 1990, Gato-Pecina et al, “Use of the Paracellular Way for the Intestinal Absorption of Sugars” & Revista Espanola De Fisiologia, vol. 46, No. 4, 1990, pp. 343-352.
Krejs et al, “Effect of Protonated 2,4,6-Triaminopyrimidine, a Tight Junction Blocker, on Intestinal Transport in Dog Ileum in Vivo”, Gastroenterology, Saunders, Philadelphia, PA, U, vol. 72, No. 4, Part 1, 1977, pp. 685-691.
Kinugasa et al, “Clauding Regulate the Intestinal Barrier in Response to Immune Mediators”, Gastroenterology, W.B. Saunders Company, Philadelphia, US, vol. 118, No. 6, Jun. 2000, pp. 1001-1011.
Pothoulakis, “Effects of Clostridium Difficile Toxins on Epithelial Cell Barrier”, Annals of the New Academy of Sciences, New York Academy of Sciences, New York, NY, US, vol. 915, 2000, pp. 347-356.
Hollander, “Intestinal Permeability, Leaky Gut, and Intestinal Disorders”, Current Gastroenterology Reports, Current Science, US, vol. 1, No. 5, Oct. 1999.
Perry et al, “Intestinal permeability in coeliac disease”, LANCET, XX, XX, vol. 358, No. 9294, Nov. 17, 2001, pp. 1729-1730.
Perry et al, “Reduced Expression of Z0-1 and Gamma Catenin in the Small Intestinal Mucosa of Untreated Cellac Disease”, Gastroenterology, W.B. Saunders Company, Philadelphia, US, vol. 118, No. 4, Apr. 2000, p. AGAA369.
Choon Jin Ooi et al, “Regulation of Tight Junction Proteins in Human Subjects with Inflammatory Bowel Disease” Gastroenterology, W.B. Saunders Company, Philadelphia, Us, Vol. 118, No. 4, Apr. 2000, pp. AGAA795.
Ma et al, “Cytochalasin B Modulation of Caco-2 Tight Junction Barrier: Role of Myosin Light Chain Kinase”, American Journal of Physiology: Gastrointestinal and Liver Physiology, American Physiological Society, US, vol. 279, No. 5, Nov. 2000, pp. G875-G885.
Ma et al, “Mechanism of Extracellular Calcium Regulation of Intestinal Epithelial Tight Junction Permeability: Role of Cytoskeletal Involvement”, Microscopy Research and Technique, Wiley-Liss, Chichester, GB, vol. 51, No. 2, Oct. 15, 2000, pp. 156-168.
Database Medline: US National Library of Medicine (NLM), Bethesda, MD, US; Jun. 2000 Mankertz et al, “Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma” & Journal of Cell Science, England, Jun. 2000, vol. 113, (Pt 11), Jun. 2000, pp. 2085-2090.
Banan et al, “Carbonylation and Disassembly of the F-Actin Cytoskeletin in Oxidant Induced Barrier Dysfunction and Its Prevention by Epidermal
Nixon & Vanderhye P.C.
Rytek
Spivack Phyllis G.
LandOfFree
Methods for treating digestive functional pathologies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating digestive functional pathologies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating digestive functional pathologies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4049179